Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2008
01/08/2008US7317087 Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof
01/08/2008US7317086 An isolated human nucleic acid encoding a nevoid basal cell carcinoma syndrome protein, antibodies, detecting tumor protein, therapeutic treatment of tumor, cancer; genetic engineering
01/08/2008US7317083 PRO4501 polypeptides
01/08/2008US7317081 PRO4371 polypeptides
01/08/2008US7317074 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage
01/08/2008US7317002 Site-specific preparation of polyethylene glycol-GRF conjugates
01/08/2008US7316931 Mass defect labeling for the determination of oligomer sequences
01/08/2008US7316929 Label comprising first encoded calibration information and second encoded calibration information. The second encoded calibration information may correspond to a different instrument than the first encoded calibration information. The
01/08/2008US7316926 Brain capillary cells; culture product
01/08/2008US7316913 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls
01/08/2008US7316912 Tyrosylprotein sulfotransferases and methods of use thereof
01/08/2008US7316910 Rapid test for hemolytic streptococcus
01/08/2008US7316909 Binding protein as biosensors
01/08/2008US7316908 Peptides from the E2 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
01/08/2008US7316907 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types
01/08/2008US7316906 Diagnosing cancer in humans; obtain lymphocytes, monitor preferential cd antigen expression, compare to control, evaluate for cancer
01/08/2008US7316905 Method for measurement of hepatitis C virus
01/08/2008US7316902 Compositions that specifically bind to colorectal cancer cells and methods of using the same
01/08/2008US7316900 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer
01/08/2008US7316899 Apparatus for high speed characterization and discrimination of toxins and/or bacteria in medical, food/beverage and environmental solutions
01/08/2008US7316898 Method of determining adenovirus particle concentration
01/08/2008US7316897 Isolation of preferential parasitic cells; incubate cells with modulators, monitor cell migration, compare to control, recover preferential parasitic cells
01/08/2008US7316779 Filtration system and method for obtaining a cytology layer
01/08/2008US7316770 Method of electrophoresis, electrophoresis apparatus and capillary array
01/08/2008US7316322 Quality evaluation apparatus for fruits and vegetables
01/08/2008CA2577229C Electrochemical method
01/08/2008CA2422072C Fluorescence polarization-based homogeneous assay for fumonisin determination in grains
01/08/2008CA2358504C Methods of determining an increased risk of a woman carrying a downs syndrome affected fetus by measuring an analyte in a biological sample
01/08/2008CA2331781C De novo dna cytosine methyltransferase genes, polypeptides and uses thereof
01/08/2008CA2328244C Device for the collection, storage and/or transport of gas samples
01/08/2008CA2324028C Retroviral packaging cell line
01/08/2008CA2321763C Cell separation device and metering syringe
01/08/2008CA2311322C Method and equipment for controlling properties of paper
01/08/2008CA2299325C A digital imaging system for assays in well plates, gels and blots
01/08/2008CA2248792C Methods for measurement of lymphocyte function
01/08/2008CA2245261C Method for measuring ldl-cholesterol
01/08/2008CA2228060C Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
01/08/2008CA2225183C Novel foam proteins and use thereof
01/08/2008CA2211126C Ball and socket closure
01/08/2008CA2163868C Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
01/08/2008CA2104111C Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
01/04/2008CA2595164A1 An antibody which recognizes phosphorylated polypeptides
01/04/2008CA2591804A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases
01/04/2008CA2557772A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases
01/04/2008CA2551537A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases
01/03/2008WO2008003024A2 Method and composition for diagnosing endometrial cancer
01/03/2008WO2008002987A2 Authentication of ingestible products using saccharides as markers
01/03/2008WO2008002911A2 Urate metabolites as diagnostic markers for cardiovascular and renal disease
01/03/2008WO2008002745A2 Method for a fully automated monoclonal antibody-based extended differential
01/03/2008WO2008002656A2 Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof
01/03/2008WO2008002620A2 Cell model for alzheimer's disease pathology
01/03/2008WO2008002611A2 Delta-tocotrienol treatment and prevention of pancreatic cancer
01/03/2008WO2008002462A2 Methods and devices for microfluidic point-of-care immunoassays
01/03/2008WO2008002267A1 A sensor kit and a system for detecting an analyte in a test environment
01/03/2008WO2008002236A1 Method of detecting interactions between protein components
01/03/2008WO2008002185A1 System for measuring components of a three-component gas-liquid flow of oil wells
01/03/2008WO2008002166A2 Diagnosis of fasciolosis by skin test (intradermoreaction) using the antigen fh8 (fasciolin).
01/03/2008WO2008002165A2 A method, assay and kit for prediction and treatment of a human subject infected with a virus
01/03/2008WO2008002113A1 Apparatus for collection and analysis of human body fluids
01/03/2008WO2008001944A1 Reagent for detection of autoantibody and kit for diagnosis of autoimmune disease
01/03/2008WO2008001903A1 Fad-conjugated glucose dehydrogenase gene
01/03/2008WO2008001868A1 Kit for detection/quantification of analyte, and method for detection/quantification of analyte
01/03/2008WO2008001796A1 Panel for analysis and analyzer using the same
01/03/2008WO2008001748A1 Sensor element for spr measurement
01/03/2008WO2008001640A1 Component concentration monitoring device of stain solution, component concentration control device and dyeing device
01/03/2008WO2008001614A1 Nonalcoholic steatohepatitis model animal and fatty liver model animal
01/03/2008WO2008001498A1 Model animal of dendritic cell immunoreceptor gene knockout disease
01/03/2008WO2008001361A2 Systèmes de dépistage utilisant rtp801l
01/03/2008WO2008001357A2 Methods and kits for diagnosing cancer
01/03/2008WO2008001235A2 An in vitro method of detecting and/or diagnosing cancer using uv light based dna image cytometry
01/03/2008WO2008001130A1 Biomarkers for preeclampsia
01/03/2008WO2008001091A1 Sensor calibration
01/03/2008WO2008001084A1 Multiple labelling for analyte detection
01/03/2008WO2008001079A1 Methods for identifying modulators of eoxin formation
01/03/2008WO2008001045A1 Members of the glycoside hydrolase family 31 family of proteins
01/03/2008WO2008000918A1 Novel cellular glycan compositions
01/03/2008WO2008000866A1 Method of chemically modifying polymer surfaces intended for immobilizing molecules
01/03/2008WO2008000785A1 A screening method for identifying new drugs
01/03/2008WO2008000512A2 Method for identifying crmp modulators
01/03/2008WO2008000223A1 Spatially-resolved measurement method for the detection of melanin in fluorophor mixtures in a solid sample
01/03/2008WO2008000186A1 A method for identifying novel gene and the resulting novel genes
01/03/2008WO2008000070A1 Glycyrrhetinic acid derivatives
01/03/2008WO2008000060A1 Microfluidic methods for nucleic acid monitoring
01/03/2008WO2008000031A1 Bead immobilisation method and bead arrays made thereby
01/03/2008WO2008000023A1 Detection of influenza virus
01/03/2008WO2007131739A3 Gas detector having an acoustic measuring cell and selectively adsorbing surface
01/03/2008WO2007128570A3 In vitro method for the identification and early identification and for the concomitant monitoring of the therapy of drug- and addictive substance-induced liver damage
01/03/2008WO2007126455A3 Method for using boc/cdo to modulate hedgehog signaling
01/03/2008WO2007125324B1 Method of screening for an antagonist of adiponectin receptor 2 and uses thereof
01/03/2008WO2007124023A3 Ink-jet printing of tissues
01/03/2008WO2007112217A3 Self calibrating measurement system
01/03/2008WO2007110702A3 Assays
01/03/2008WO2007109465A3 Lanthanide complexes as fluorescent indicators for neutral sugars and cancer diagnosis
01/03/2008WO2007103859A3 Methods, products, and kits for identifying an analyte in a sample
01/03/2008WO2007099338A8 Method and apparatus for detecting a substance of interest
01/03/2008WO2007091056A3 Bicyclic compounds and their use
01/03/2008WO2007085898A3 Improved chemical identification of peroxide-based explosives
01/03/2008WO2007074247A3 Device for monitoring a product degradation
01/03/2008WO2007068478A8 Rna helicase as marker for rare tumours
01/03/2008WO2007051077A3 Methods and compounds for lymphoma cell detection and isolation